CB-01-12

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCB-01-12
Drug Alias Nameanti-TNF alpha therapeutic (Cosmo)CB-01-12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCosmo Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCosmo Pharmaceuticals NVAimm TherapeuticsCosmo Spa
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A